Accelerated TMS Therapy Shows Promise for Treatment-Resistant Depression

A new study from UCLA Health suggests that a highly concentrated course of transcranial magnetic stimulation (TMS) – delivering the treatment in just five days instead of the traditional six to eight weeks – may offer comparable relief for individuals struggling with treatment-resistant depression. This accelerated approach could significantly improve access to TMS for those who find the standard schedule challenging.

What is Transcranial Magnetic Stimulation (TMS)?

Transcranial Magnetic Stimulation (TMS) is a noninvasive therapy that uses magnetic pulses to stimulate nerve cells in the brain. It’s an established treatment option for major depression, obsessive-compulsive disorder (OCD), and chronic pain, particularly when other treatments haven’t provided sufficient benefit. The UCLA Health website details that TMS works by altering patterns of brain cell nerve firing.

The Study: Comparing Traditional TMS to the Accelerated “5×5” Protocol

Researchers at UCLA Health investigated whether a condensed TMS schedule could achieve similar outcomes to the standard protocol. The study, published in the Journal of Affective Disorders, involved 175 patients with treatment-resistant depression.

• Conventional TMS Group (135 participants): Received one TMS session per day, five days a week, for six weeks.
• Accelerated TMS Group (40 participants): Received five TMS sessions per day for five consecutive days – the “5×5” protocol.

Both groups demonstrated meaningful reductions in depression symptoms, and the study found no statistically significant difference in overall effectiveness between the two approaches.

Delayed Benefits Observed with Accelerated TMS

Interestingly, some patients in the accelerated TMS group initially showed minimal improvement immediately after completing the five-day course. However, when reassessed two to four weeks later, these individuals experienced substantial progress, with an average reduction of 36% in their depression scores. This suggests that the full benefits of the accelerated protocol may not be immediately apparent.

Expert Perspectives on the Findings

“For patients with treatment-resistant depression, getting to the clinic every weekday for at least six weeks can be a real obstacle,” said Michael Apostol, a Ph.D. Student at the UCLA Semel Institute for Neuroscience and Human Behavior and the study’s lead author. “What this study suggests is that we may be able to offer those same patients a path to meaningful relief in less than one week by condensing 25 TMS treatments over just five days.”

Dr. Andrew Leuchter, distinguished professor and director of the TMS Service of the UCLA Department of Psychiatry and Biobehavioral Sciences, added, “Some patients need to wait a few days or weeks to see benefit, and we encourage them not to give up too quickly if they don’t sense better right away. We are finding that the benefits of 5×5 can be even greater with an extra one-to-days of treatment after two weeks.”

Important Considerations and Future Research

While the accelerated method showed promising results, the researchers emphasize that the traditional six-week protocol remains well-supported by long-term evidence and demonstrated stronger results on some longer-term outcome measures in this study. It’s too important to note that this was not a randomized clinical trial, and larger, controlled studies are needed to confirm these findings.

UCLA scientists are continuing to investigate TMS for other conditions, including obsessive-compulsive disorder and chronic pain, highlighting the growing potential of brain-based therapies in mental health care. UCLA TMS Los Angeles is actively involved in research and training related to neuromodulation.

Key Takeaways

• Accelerated TMS (5×5 protocol) may be as effective as traditional TMS for treatment-resistant depression.
• Delayed benefits are possible with the accelerated protocol – patients may experience significant improvement weeks after completing treatment.
• The traditional six-week TMS protocol remains a well-established and effective treatment option.
• Further research is needed to confirm these findings and optimize the accelerated TMS approach.